These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11864500

  • 21. [Epidemiological study of renal syndrome-hemorrhagic fever: progress, problems and prospects].
    Wu X.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):262-4. PubMed ID: 12886923
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Long-term persistence of anti-hantavirus antibodies in sera of patients undergoing hemorrhagic fever with renal syndrome and subjects vaccinated against the disease.
    Zheng Y, Wei J, Zhou BY, Xu Y, Dong JH, Guan LY, Ma P, Yu PB, Wang JJ.
    Infect Dis (Lond); 2016 Apr; 48(4):262-266. PubMed ID: 26654580
    [Abstract] [Full Text] [Related]

  • 24. Seroepidemiology of Hantaan virus infection in Taiwan.
    Kao CL, Chen CJ, Yen TS, Lien JC, Yang CS.
    J Med Virol; 1996 Dec; 50(4):309-13. PubMed ID: 8950687
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Boudreau EF, Josleyn M, Ullman D, Fisher D, Dalrymple L, Sellers-Myers K, Loudon P, Rusnak J, Rivard R, Schmaljohn C, Hooper JW.
    Vaccine; 2012 Mar 02; 30(11):1951-8. PubMed ID: 22248821
    [Abstract] [Full Text] [Related]

  • 27. IgG subclasses in human immune response to wild and attenuated (vaccine) Junin virus infection.
    del Carmen Saavedra M, Sottosanti JM, Riera L, Ambrosio AM.
    J Med Virol; 2003 Mar 02; 69(3):447-50. PubMed ID: 12526057
    [Abstract] [Full Text] [Related]

  • 28. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW, Moon JE, Paolino KM, Newcomer R, McLain DE, Josleyn M, Hannaman D, Schmaljohn C.
    Clin Microbiol Infect; 2014 May 02; 20 Suppl 5():110-7. PubMed ID: 24447183
    [Abstract] [Full Text] [Related]

  • 29. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 02; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 30. Isolation, identification and certain characteristics of a Hantaan virus proposed as candidate virus for killed vaccine.
    Xie Y, Hang C, Wang H.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar 02; 14(1):27-30. PubMed ID: 11503020
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. DNA vaccines for HFRS: laboratory and clinical studies.
    Schmaljohn CS, Spik KW, Hooper JW.
    Virus Res; 2014 Jul 17; 187():91-6. PubMed ID: 24370868
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
    Song JY, Woo HJ, Cheong HJ, Noh JY, Baek LJ, Kim WJ.
    Vaccine; 2016 Mar 04; 34(10):1289-95. PubMed ID: 26826547
    [Abstract] [Full Text] [Related]

  • 37. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B, Tosun S, Ozdemir M, Doğan M.
    Mikrobiyol Bul; 2009 Jan 04; 43(1):127-31. PubMed ID: 19334389
    [Abstract] [Full Text] [Related]

  • 38. Effects of Salmonella enterica subsp. enterica serovar Enteritidis vaccination in layer hens subjected to S. Enteritidis challenge and various feed withdrawal regimens.
    Piao Z, Toyota-Hanatani Y, Ohta H, Sasai K, Tani H, Baba E.
    Vet Microbiol; 2007 Nov 15; 125(1-2):111-9. PubMed ID: 17624693
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.